Those who have dealt with drug injuries associated with controversial medications like Avandia may appreciate what some medical professionals are recommending.
According to Reuters, risky drugs need a simpler process to ensure patients’ safety when it comes to protecting them from drug injuries.
The process for protecting patients from drug injuries associated with risky drugs known as REMS (risk evaluation and mitigation strategies) should have less paperwork and be more consistent, say drug makers and pharmacy representatives.
Right now patient information packets that come with medications are the most common form of protection against drug injuries from prescription medication.
However, drug makers and pharmacy representatives are recommending more studies with high-risk medications during the drug making process. They also advocate the same safety warnings and process for similar drugs with the potential for the same time of drug injuries.